Common problems and analysis of suspected unexpected serious adverse reactions expedited reporting during drug clinical trialsPEI Xiao-jing, CUI Huan-huan, HU Yang-ping, LIU Wen-dong, CUI Can, LIU Min, LI Yan-rong, YANG Ce, WANG Hai-xue2761-2765
Ethical issues of clinical research on sudden infectious diseases and countermeasuresCHENG Jin-lian, WANG Mei-xia, XIAO Shuang, LI Bo, WANG Jing, LIU Sheng, ZHU Xue-qi, WANG Yan, LIU Qing-quan2774-2780
Discussion on the core concept for viral safety of biological productsGUO Huai-zu, YANG Mei-hua, YANG Hui-chuan, GONG Xue-jie, HOU Sheng, ZHANG Hua-jie, LI Chang-qing, DONG Guan-mu, LI Min, MENG Shu-fang, HOU Ji-feng, GUO Zhong-ping2781-2788
Progress in bacterial outer membrane vesicles as vaccine candidatesWANG Shan-shan, LI Ya-nan, XU Ying-hua, YE Qiang2789-2793
Research progress in ophthalmic microneedles drug delivery systemLU Xiao-yan, CHEN Dao-yuan, SU Lin-yu, SUN Kao-xiang2794-2800
R&D of generic transdermal patches and regulatory considerationsYOU Chun-na, SONG Zong-hua, ZHANG Qi-ming, LI You-xin, LIU Wan-hui2801-2808
Clinical efficacy of traditional Chinese medicine Lianhua Qingwen Granules in 42 suspected cases of children with Corona Virus Disease 2019FANG Fei, YANG Lei, QIN Shou-cheng, JIAO Rong2809-2812
Synthesis and biological evaluation of chrysotoxine derivatives as cholinesterase inhibitorsGUAN Li, WANG Chun-yang, HU Ya-qi, ZHAO Hui-ru, LI Wei-ze, XU Yuan-tao2813-2819
Study on the mechanism of berberine for treatment of T2DM based on network pharmacology and molecular dockingWANG Xin-yuan, HUANG Xia-bing, DENG Xin2820-2831